Sorry, your browser does not support JavaScript!
For the latest updates on Gilead’s ongoing response to COVID-19, please
click here
.
×
Investor Relations
Contact Us
KiteKonnect®
About Us
Our Mission
Our Story
Therapeutic Areas
Leadership
Kite Locations
Grants
Science & Medicine
Our Technology
Our Therapies
Pipeline
Trials & Expanded Access
External Research Program (ERP)
Newsroom
Newsroom
Media Kit
Press Releases
Company Statements
Careers
Now Hiring
Careers at Kite
Early Talent Programs at Kite
Culture & Benefits
Utility
Contact Us
KiteKonnect®
BACK TO MAIN MENU
Company Statements
Kite Announces U.S. FDA Clearance of Investigational
Investor Relations
Toggle Inner Dropdown
BACK TO MAIN MENU
Google.com
Compliance Program
Gilead Ethics and Code of Conduct
US Disclosures
California
